5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 29.40▲ | 28.96▲ | 28.61▲ | 28.18▲ | 24.66▲ |
MA10 | 29.56▼ | 28.56▲ | 28.63▲ | 26.65▲ | 26.67▲ |
MA20 | 29.18▲ | 28.57▲ | 28.51▲ | 24.62▲ | 31.47▼ |
MA50 | 28.60▲ | 27.80▲ | 26.77▲ | 26.67▲ | 48.22▼ |
MA100 | 28.57▲ | 26.64▲ | 25.14▲ | 32.20▼ | 39.34▼ |
MA200 | 28.40▲ | 24.85▲ | 24.81▲ | 46.31▼ | 22.97▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.019▼ | 0.062▲ | -0.051▼ | 0.828▲ | 0.340▲ |
RSI | 62.459▲ | 65.234▲ | 68.367▲ | 62.666▲ | 42.078▼ |
STOCH | 38.091 | 60.100 | 54.069 | 82.067▲ | 31.601 |
WILL %R | -31.900 | -22.646▲ | -18.977▲ | -5.100▲ | -39.382 |
CCI | 16.199 | 168.428▲ | 277.889▲ | 150.681▲ | -5.424 |
Thursday, May 01, 2025 02:47 AM
Viking Therapeutics (NASDAQ: VKTX) was one of the hottest biotech stocks of 2024; its shares soared last year following excellent clinical progress. Should you steer clear of Viking Therapeutics? The ...
|
Wednesday, April 30, 2025 04:51 AM
The market for obesity drugs presents one of the most lucrative targets for biopharmaceutical companies. Eli Lilly and Novo Nordisk are already raking in billions of dollars in sales with their weight ...
|
Wednesday, April 30, 2025 01:50 AM
Altimmune and Viking Therapeutics have promising obesity drugs and could be great acquisition targets for Pfizer. Pfizer should be able to easily fund an acquisition of either small drugmaker. The ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
02/05/25 | 29.23 | 29.955 | 29.21 | 29.51 | 1,077,350 |
01/05/25 | 28.91 | 29.01 | 27.69 | 28.615 | 3,465,486 |
30/04/25 | 27.48 | 29.02 | 27.06 | 28.87 | 5,243,562 |
29/04/25 | 27.04 | 29.68 | 26.58 | 27.96 | 10,149,037 |
28/04/25 | 25.11 | 26.42 | 24.32 | 25.94 | 3,460,852 |
25/04/25 | 25.14 | 25.40 | 24.36 | 24.99 | 3,960,974 |
24/04/25 | 26.09 | 26.85 | 24.87 | 25.66 | 3,532,010 |
23/04/25 | 26.09 | 26.95 | 25.70 | 25.79 | 4,251,247 |
22/04/25 | 24.04 | 25.54 | 24.00 | 25.48 | 3,561,991 |
21/04/25 | 23.83 | 24.6827 | 23.30 | 23.72 | 2,724,745 |
|
|
||||
|
|
||||
|
|